- GENFIT annonce de nouvelles données au congrès 2023 de l’European Association for the Study of the Liver (EASL)
- GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023
- GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
- GENFIT renforce sa franchise ACLF avec un troisième composé de stade clinique
- GENFIT: May 24, 2023 Combined Shareholders Meeting results
- GENFIT : Résultats de l’Assemblée Générale Mixte du 24 mai 2023
- GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology
- GENFIT annonce la publication présentant le développement et la validation de NIS2+™ dans le Journal of Hepatology
- GENFIT : Information financière du premier trimestre 2023
- GENFIT Reports First Quarter 2023 Financial Information
More ▼
Key statistics
As of last trade, Genfit SA (XUPB:BER) traded at 3.84, 29.73% above the 52 week low of 2.96 set on Jun 14, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.82 |
---|---|
High | 3.90 |
Low | 3.82 |
Bid | 3.62 |
Offer | 4.08 |
Previous close | 3.78 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.83m |
Free float | 43.23m |
P/E (TTM) | -- |
Market cap | 203.64m USD |
EPS (TTM) | -0.5148 USD |
Data delayed at least 15 minutes, as of Jun 09 2023 19:30 BST.
More ▼